GoBroad Healthcare Group Showcases Advances in Cancer Immunotherapy at White Nights 2026

St. Petersburg, Russia — At the White Nights St. Petersburg International Oncology Forum 2026, Dr. Haifeng Qin of GoBroad Healthcare Group (GHG) was invited to present the group's latest clinical perspectives on cancer immunotherapy, joining leading oncology experts from around the world to discuss emerging innovations in cancer treatment.

Dr. Qin delivered a presentation entitled "Reconstructing the Tumor Immune Ecosystem: Cellular Immunotherapy for Solid Tumors and Cancer Vaccines as Driving Forces of a New Paradigm in Cancer Treatment." The presentation explored the evolving role of cellular immunotherapy for solid tumors and therapeutic cancer vaccines, highlighting their potential to reshape the tumor immune ecosystem and contribute to more effective, personalized treatment strategies.

Drawing on clinical experience and ongoing research, Dr. Qin discussed how advances in immunotherapy are expanding treatment possibilities for patients with solid tumors. His presentation emphasized the importance of integrating innovative cellular therapies and cancer vaccines into future oncology practice, with the goal of improving patient outcomes and advancing precision medicine.

White Nights is one of the leading international oncology forums, bringing together clinicians, researchers, and industry experts to exchange scientific knowledge and promote global collaboration in cancer research and treatment. Dr. Qin's participation reflects GoBroad Healthcare Group's continued commitment to contributing to international academic dialogue and fostering collaboration across the global oncology community.

Guided by a commitment to innovation and patient-centered care, GoBroad Healthcare Group continues to advance clinical research, strengthen international partnerships, and explore next-generation immunotherapy approaches that may help improve the future of cancer treatment.